Sirtris Pharmaceuticals, Inc. (SIRT) Announced Receipt of Cash Tender Offer for Outstanding Shares from GlaxoSmithKline plc
Sirtris Pharmaceuticals, Inc. (SIRT), a biopharmaceutical company that develops proprietary, orally available, small molecule drugs to treat metabolic diseases, announced…